TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 47 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $69,000 | +885.7% | 120 | +100.0% | 0.00% | -50.0% |
| Q3 2016 | $7,000 | -22.2% | 60 | 0.0% | 0.00% | -33.3% |
| Q2 2016 | $9,000 | -76.3% | 60 | -76.9% | 0.00% | -76.9% |
| Q1 2016 | $38,000 | -11.6% | 260 | -7.1% | 0.01% | -18.8% |
| Q4 2015 | $43,000 | -88.3% | 280 | -89.1% | 0.02% | -87.2% |
| Q3 2015 | $369,000 | -10.9% | 2,580 | -10.4% | 0.12% | 0.0% |
| Q2 2015 | $414,000 | +9.5% | 2,880 | +7.5% | 0.12% | +28.9% |
| Q1 2015 | $378,000 | +29.0% | 2,680 | +35.4% | 0.10% | +27.6% |
| Q4 2014 | $293,000 | -12.5% | 1,980 | -9.2% | 0.08% | -28.3% |
| Q3 2014 | $335,000 | -14.1% | 2,180 | -21.6% | 0.11% | +19.1% |
| Q2 2014 | $390,000 | +14.0% | 2,780 | -9.7% | 0.09% | -7.3% |
| Q1 2014 | $342,000 | +4.9% | 3,080 | -6.7% | 0.10% | +1.1% |
| Q4 2013 | $326,000 | +10.1% | 3,300 | -15.4% | 0.10% | +8.0% |
| Q3 2013 | $296,000 | – | 3,900 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Claret Asset Management Corp | 86,474 | $6,524,000 | 1.34% |
| Analyst IMS Investment Management Services Ltd. | 28,438 | $2,143,000 | 0.64% |
| ALGERT GLOBAL LLC | 20,876 | $1,575,000 | 0.59% |
| Quantinno Capital Management LP | 9,351 | $706,000 | 0.48% |
| Crestline Management, LP | 37,000 | $2,792,000 | 0.45% |
| Empirical Finance, LLC | 9,561 | $721,000 | 0.20% |
| BRANDES INVESTMENT PARTNERS, LP | 55,065 | $5,469,000 | 0.14% |
| FORT, L.P. | 9,672 | $730,000 | 0.14% |
| CAXTON ASSOCIATES LP | 8,865 | $669,000 | 0.13% |
| ACADIAN ASSET MANAGEMENT LLC | 330,448 | $24,928,000 | 0.11% |